Antheia

Antheia is a pharmaceutical ingredient manufacturer using advanced biomanufacturing to transform essential medicine supply chains. The company's biomanufacturing platform enables efficient and on-demand production of key starting materials and active pharmaceutical ingredients, addressing drug shortages and improving global access to essential medicines.

Funding Round: Series C

Funding Amount: $56M

Date: 03-Jun-2025

Investors: Global Health Investment Corporation (GHIC), EDBI, ATHOS KG, Federov, Viking Global Investors, Sherpalo Ventures, S-Cubed Capital, In-Q-Tel (IQT), Civilization Ventures

Markets: Biotech, Pharma, Healthtech

HQ: Menlo Park, California, United States

Founded: 2015

Website: https://www.antheia.bio/

LinkedIn: https://www.linkedin.com/company/antheiabio

Twitter: https://twitter.com/antheiabio

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/antheia

Pitchbook: https://pitchbook.com/profiles/company/119398-06


Similar Startups


Leave a Comment

    🔷 Buy VC Database 🟩 Buy Startup Database 🎁 Get Free Sample

    Share this: